ClinicalTrials.Veeva

Menu
G

GenesisCare | North Shore Health Hub - Oncology Research

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Gemcitabine
BCG
Narmafotinib
Mitomycin

Parent organization

This site is a part of GenesisCare

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 3 total trials

A Study of Narmafotinib Given in Combination With Modified FOLFIRINOX in Patients With Metastatic Pancreatic Cancer

This study is testing narmafotinib, a type of drug called a focal adhesion kinase (FAK) inhibitor, when it is given in combination with 4 chemotherap...

Not yet enrolling
Pancreatic Cancer Metastatic
Drug: narmafotinib dose comparison
Drug: narmafotinib ascending doses

This is a multicentre, open label, two-part study to determine whether the focal adhesion kinase (FAK) inhibitor AMP945, when given prior to dosing w...

Active, not recruiting
PDAC
Pancreatic Ductal Adenocarcinoma
Drug: AMP945 ascending doses
Drug: AMP945 RP2D

Trial sponsors

A
U

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems